Product
CD19.CAR T Cells
1 clinical trial
7 indications
Indication
Acute Lymphoblastic LeukemiaIndication
AdultIndication
PediatricIndication
Chronic Lymphocytic LeukemiaIndication
Diffuse Large B-Cell LymphomaIndication
Follicular LymphomaIndication
mantle cell lymphomaClinical trial
Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Lymphocytes Transduced by RV-SFG.CD19.CD28.4-1BBzeta Retroviral Vector - a Unicenter Phase I/II Clinical TrialStatus: Recruiting, Estimated PCD: 2024-01-01